Teva Pharmaceuticals USA: Valsartan and Hydrochlorothiazide (HCTZ) Tablets, USP
Recall reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.. Recalled by Teva Pharmaceuticals USA. Distribution: Product was distributed throughout the United States, including Hawaii and Puerto Rico. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot Numbers: 1191160M, 1191161M, 1191162A, 1219363M, 1219364M, 1219365A, 1225613A, 1233944M, 1233945M, 1253253M, 125325. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report